3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Equity Bancshares filed unaudited financial statements and MD&A for Frontier Holdings LLC, which it acquired effective January 1, 2026, for the three months ended December 31, 2025. The filing was made to support an S-4 registration for the pending Lincoln Bancorp transaction and does not change Equity's own reported financial statements. Frontier reported a net loss, which is a change from a year-earlier profit, although its net interest income rose.
Frontier reported a net loss of $891,000 for the quarter ended December 31, 2025, versus net income of $2.9 million a year earlier.
Net interest income rose to $10.9 million from $9.2 million, while total noninterest expense rose to $12.4 million from $6.6 million.
Frontier's total assets were $1.43 billion at December 31, 2025, and its loans were $1.29 billion.
Vistra Operations Company LLC, a wholly owned subsidiary of Vistra Corp., amended its commodity-linked credit agreement effective September 30, 2026. The amendment extends the revolving credit maturity date by one year and aligns other terms with the subsidiary's corporate credit agreement. The filing does not disclose the size of the facility or any change in borrowing amounts, so the effect on shareholders appears administrative.
Revolving Credit Maturity Date extended from September 30, 2026 to September 29, 2027
Amendment signed September 30, 2026 with Citibank, N.A. as administrative agent
Other amendments made to conform with the Borrower's Corporate Credit Agreement
Stockholders approved moving Outdoor Holding from Delaware to Texas at the September 28, 2026 annual meeting, and the conversion took effect September 30, 2026. The filing says the change did not alter the company's business, management, employees, assets or liabilities, and that stockholders do not need to exchange their shares, but certain stockholder rights did change.
Approval vote on the Texas redomestication: 74,116,057 for, 10,985,633 against, 268,587 abstentions, with 14,638,384 broker non-votes.
Effective at 10:59 p.m. Central Time on September 30, 2026; common and 8.75% Series A preferred stock converted one-for-one and continue trading on Nasdaq as POWW and POWWP.
Steven F. Urvan, Chairman and CEO, was also appointed President effective at the Effective Time; the company is moving its headquarters from Atlanta, Georgia to Dallas, Texas.
ChronoScale Holdings completed the sale of its Ekso Bionics subsidiary on September 30, 2026, and said it will focus on its AI infrastructure business. On October 1, 2026, it also announced an expanded agreement with an existing AI infrastructure customer and a new customer agreement, which together with existing contracts provide for $1 billion in annualized revenue run rate by calendar Q3 2027. The filing does not disclose the sale price or the company's profit results, and the revenue run-rate is a non-GAAP measure subject to deployment and financing risks.
Sale of Ekso Bionics, Inc., a wholly owned subsidiary, completed September 30, 2026; the filing does not state the sale price
Expanded AI infrastructure customer agreement and new customer agreement, announced October 1, 2026, with combined contracts targeting $1 billion annualized revenue run rate by calendar Q3 2027
Chief Operating Officer of Ekso, Jason C. Jones, terminated effective September 30, 2026, with severance of $243,750 plus up to nine months of COBRA premiums
Series B Convertible Preferred Stock designation withdrawn September 29, 2026; no preferred shares were outstanding
At its September 29, 2026 annual meeting, Richtech Robotics stockholders elected Saul Factor and John Shigley to three-year board terms expiring at the 2029 annual meeting. Stockholders also ratified CBIZ CPAs P.C. as the independent registered public accounting firm for the current fiscal year.
Saul Factor received 389,423,507 votes for and 16,833,265 votes withheld.
John Shigley received 401,733,521 votes for and 4,523,251 votes withheld.
The auditor ratification received 405,557,046 votes for, 589,622 against and 110,104 abstentions.
The annual meeting was held September 29, 2026; the 8-K was dated October 2, 2026.
Healthcare Triangle, Inc. received a Nasdaq Staff Delisting Determination because its closing bid price has been below $1.00 and the company is not eligible for a compliance period after cumulative reverse stock splits of 1-for-14,940 over two years. The company intends to request a Panel hearing, which would stay suspension, and its shares continue to trade as HCTI for now, but without a successful appeal the stock would be suspended from Nasdaq on October 12, 2026.
Nasdaq notice dated October 1, 2026 cites failure to meet the $1.00 minimum bid price under Rule 5550(a)(2)
Company is ineligible for a compliance period after a 1-for-249 reverse split (August 1, 2025) and a 1-for-60 reverse split (February 10, 2026)
Appeal to a Nasdaq Hearings Panel must be requested by October 8, 2026; otherwise trading suspension begins October 12, 2026
Company intends to request a hearing and may propose a reverse stock split; the Panel's outcome is not assured
On October 1, 2026, Tonix Pharmaceuticals received notice that Dr. Reddy's Laboratories had filed an ANDA with the FDA for a generic version of TONMYA, challenging four Orange Book patents. The filing matters to shareholders because it signals possible generic competition for TONMYA, and the company says it intends to vigorously enforce its intellectual property rights but cannot predict the outcome.
Notice received October 1, 2026 from Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc.
ANDA covers a generic version of TONMYA (cyclobenzaprine hydrochloride) sublingual tablets, 2.8 mg, with a Paragraph IV certification
Certification targets U.S. Patent Nos. 9636408, 9956188, 10117936 and 10864175, all listed in the Orange Book
A patent infringement suit filed within 45 days of the notice would automatically block FDA approval of the ANDA for up to 30 months, subject to the outcome of litigation
On October 2, 2026, Planet Green Holdings Corp. entered into an ATM Sales Agreement with Craft Capital Management LLC, allowing it to sell common stock through the agent on the NYSE American. The company says it is eligible to sell up to approximately $22,539,922 of stock under SEC baby-shelf limits, but it is not obligated to sell any shares and has not yet stated any sales. Shareholders may face dilution if the company sells shares under the program.
Agreement is with Craft Capital Management LLC, dated October 2, 2026.
Eligible sales capped at approximately $22,539,922, one-third of a public float of about $67.6 million.
Company pays the agent a 4.0% commission on gross proceeds from each sale.
Shares would be sold under a Form S-3 shelf registration effective April 13, 2026.
HeartSciences entered Amendment No. 8 to its Loan and Security Agreement and a No. 4 Amended and Restated Secured Promissory Note with Front Range Ventures LLC, both dated September 29, 2026. The amendment extends the maturity of the note, which funded a $500,000 borrowing, to the earlier of two business days after closing of the proposed business combination with Fortitude Mining Holdings, Inc. or January 29, 2027. The filing states the change to the note's terms but does not report any change in the loan amount.
The note's maturity date is extended to the earlier of two business days after the Fortitude Mining Holdings, Inc. business combination closes or January 29, 2027.
Accrued unpaid interest as of September 30, 2026 is payable on or before that date; later accrued interest is payable at maturity.
The company may repay all or part of the principal at any time before maturity, in amounts of at least $50,000, applied first to interest.
On September 30, 2026, Pinterest's board amended and restated its severance and change-in-control plan for employees in Level 21 positions, effective that day. The changes include a bonus formula for terminations tied to a change in control and a revised good reason definition that covers bonus cuts above 10%.
Plan covers certain employees in job category Level 21; amended and restated effective September 30, 2026.
Non-change-in-control termination: pro-rated target annual bonus, subject to a separation and release agreement.
Change-in-control termination: greater of target bonus or bonus based on actual performance; single-trigger equity acceleration only if awards are not assumed or replaced.
Good reason now includes a reduction of more than 10% in target annual bonus; full plan text to be filed with the next 10-Q.
Live Nation amended and restated CEO Michael Rapino's employment agreement, effective October 1, 2026, keeping him as President, CEO and board member through December 31, 2031. Base salary and target cash bonus are unchanged from his existing agreement, while the filing adds a $20 million upfront RSU grant and annual equity grants beginning in 2027.
Term runs from October 1, 2026 to December 31, 2031; agreement approved unanimously by the Board with Rapino abstaining
Base salary of $3,000,000 and target annual cash bonus of $17,000,000 (from 2027), same as the prior agreement
Upfront RSU grant of $20,000,000 on the Effective Date, plus annual grants of $10,000,000 in performance shares, $15,000,000 in time-based RSUs and $15,000,000 in target PSUs starting in 2027
Severance on termination without cause or for good reason is a lump sum equal to two times base salary, bonus and recent Annual Performance Shares value, plus full equity acceleration
BIO-key International entered four Exchange Agreements on September 29, 2026 with lender Streeterville Capital, LLC, converting $416,315.80 of principal from its September 30, 2025 secured note into four new promissory notes that were then exchanged for 247,805 shares of common stock. The filing says the original $1,130,000 note has now been paid in full, and the share issuance was unregistered under Section 3(a)(9) of the Securities Act, so it adds to the share count.
Exchange Agreements dated September 29, 2026 with Streeterville Capital, LLC
$416,315.80 of Original Note principal exchanged, with the Original Note described as paid in full
Issued 247,805 unregistered shares of common stock under Section 3(a)(9) of the Securities Act
RTB Digital's Board appointed Mary Elizabeth Truss, the former Prime Minister of the United Kingdom, as a director on September 30, 2026. She will receive a prorated restricted stock unit award tied to a $150,000 annual grant-date fair value under the Company's standard Board of Directors Agreement.
Appointed as director on September 30, 2026; serves until a successor is elected and qualified
Annual equity award with a grant-date fair value of $150,000, paid as restricted stock units, prorated for 2026
RSUs vest in full on December 31 of the applicable year, subject to continued service
Filing states no arrangement with other persons for selection and no related-party transactions under Item 404(a)
Dragonfly Energy amended its senior secured term loan, with lenders waiving the minimum liquidity covenant test for the month ending September 30, 2026, and agreeing to waive any default tied to a deferred portion of the October 1, 2026 Series B preferred dividend. The company also agreed to a $450,000 amendment fee added to the loan principal, and the Series B holders waived their right to the full dividend on time, which means shareholders face a modified payment schedule and a larger loan balance.
Lenders waived testing of the minimum liquidity covenant solely for the fiscal month ending September 30, 2026.
The company will pay a $450,000 amendment fee, paid in kind by adding it to the outstanding Term Loan principal.
Series B holders waived the full October 1, 2026 dividend; the company must pay a 2% per annum cash dividend by October 1, 2026 and a 6% per annum cash dividend by October 30, 2026, with 2% per annum paid in kind.
Xcel Brands, Inc. received a letter from Nasdaq on September 29, 2026, saying its common stock closed below $1.00 per share for 30 consecutive business days, so it does not meet the minimum bid price requirement. The company has until March 29, 2027 to regain compliance, which requires a closing bid price of at least $1.00 for 10 consecutive business days; if it cannot, its shares could face delisting from the Nasdaq Capital Market.
Nasdaq notice dated September 29, 2026 cites a bid price below $1.00 for 30 consecutive business days.
Compliance period runs 180 calendar days, until March 29, 2027.
Regaining compliance requires a closing bid of at least $1.00 for 10 consecutive business days.
A reverse stock split may be needed; the company says there is no assurance it will regain compliance.
Aveanna Healthcare director Steven E. Rodgers, a Class II director who sat on the Audit and Compensation Committees, resigned from the board effective immediately, as disclosed in an October 2, 2026 filing. The company said the resignation was not due to any disagreement on operations, policies, or practices, and the filing does not name a replacement.
Steven E. Rodgers notified the company of his resignation on October 1, 2026, effective immediately.
He was an independent Class II director serving on the Audit Committee and the Compensation Committee.
The company states the resignation was not due to any disagreement with the company on operations, policies, or practices.
The filing does not name a successor or new committee assignments.
Gold.com entered into a Second Amended and Restated Credit Agreement with CIBC Bank USA as administrative agent on September 29, 2026. The uncommitted revolving line is payable on demand and is reduced from $427.5 million to $250 million, while many caps on dividends, buybacks, acquisitions and metals-related arrangements are removed or loosened.
Facility reduced from $427,500,000 to $250,000,000
Converted to an uncommitted revolving line of credit payable on demand
Caps on special and recurring dividends and share repurchases removed, subject to conditions
Agreement dated September 29, 2026; filed October 2, 2026
PROCEPT BioRobotics increased its board from nine to ten members and appointed Dr. Michael Mack, a cardiac surgeon, as a director effective immediately. The Board determined Mack is independent under SEC and Nasdaq rules, which adds an independent director with extensive thoracic surgery and medical society leadership experience.
Dr. Michael Mack appointed as Class II director; term expires at the 2029 annual meeting
Board size increased from nine members to ten effective October 2, 2026
Board determined Mack is independent under SEC and Nasdaq rules
Mack will receive non-employee director compensation and sign the Company's standard indemnification agreement
KinderCare Learning Companies (NYSE: KLC) said director Michael Nuzzo resigned from its board effective September 29, 2026, to devote time to other commitments, and that the resignation was not due to any disagreement with the company. The board filled the seat with Preston Grasty of Partners Group and named David Barse as Audit Committee chair, a change in board composition that does not alter reported financial results.
Michael Nuzzo resigned from the board, a Class II director seat, effective September 29, 2026, and also left the Audit and Compensation committees.
David Barse was appointed to the Audit Committee and named its chair, and to the Compensation Committee, effective September 29, 2026.
Preston Grasty, a Senior Investment Leader at Partners Group, was appointed to fill the vacancy as a Class II director through the 2029 annual meeting and joined the Nominating and Corporate Governance Committee.
Verra Mobility's board appointed Jon Newhard as President and Chief Executive Officer, effective November 1, 2026, and as a director on the same date, which increases the board from six to seven members. He succeeds Jon Keyser, the interim CEO since June 2026, who will serve in an advisory role until December 31, 2026, while severance terms with Mr. Keyser are still being negotiated. The filing sets Mr. Newhard's base salary at $725,000 and includes a $4,750,000 inducement RSU award that remains subject to approval.
Jon Newhard, 57, was CEO of Yunex Traffic GmbH from March 2024 until September 2026 and previously led Clinc, Inc. and Cubic's ITS division.
Base salary of $725,000, with a target bonus of 100% of base salary and an estimated target equity grant date fair value of $4,000,000 beginning in fiscal 2027.
Inducement RSU award with a grant-date fair value of $4,750,000, subject to NASDAQ Listing Rule 5635(c)(4) approvals and vesting over three annual installments.
Jon Keyser remains in an advisory role until December 31, 2026, and the company is negotiating his severance arrangements.
US Foods, Inc. entered into a Fourteenth Amendment to its credit agreement on October 2, 2026, adding a new $810 million senior secured term loan due October 2, 2033. Proceeds, along with cash on hand, were used to repay and prepay existing term loans and certain revolving loans under its asset-based facility, and to pay fees and expenses. The filing does not report earnings or guidance, so its direct effect on shareholders is a refinancing of existing debt and new secured borrowing terms.
New 2026 Term Loan Facility totals $810 million and matures October 2, 2033.
Interest is Term SOFR plus 1.50%, or an alternative base rate plus 0.50%.
Loans amortize at 1% per year in quarterly installments, with the balance due at maturity.
Loans are secured by the company's capital stock and substantially all non-real estate assets, with a 1.00% premium on repricing transactions within six months of closing.
Silo Pharma agreed on October 1, 2026 to buy software, technology and related intellectual property from Norsight Consulting Inc. In payment, it issued Norsight a warrant to buy up to 300,000 shares of common stock at $1.51 per share, a sale made without registration. The filing describes no cash consideration, so the deal adds potential dilution for shareholders while expanding the company's asset base.
Asset purchase agreement dated October 1, 2026 with Norsight Consulting Inc., an Arkansas corporation
Warrant covers up to 300,000 shares at an exercise price of $1.51 per share, exercisable from April 1, 2027 and expiring September 30, 2031
Seller may not hold more than 4.99% of outstanding common stock after exercise, and may not exceed 9.99% without at least 61 days' notice
Shares received by the seller are locked up for up to 12 months, or until a change in control or the company's written consent
On September 28, 2026, HF Foods amended CEO Felix Lin's employment agreement and entered new employment agreements with CFO Paul McGarry and CAO Christine Chang. The company also amended its Severance Plan and the form of its RSU and PSU award agreements, and changed outstanding awards. The filing gives no dollar amounts, but the changes affect when severance and equity benefits apply to executives, which matters to shareholders because it can affect future executive payouts.
Non-renewal by the company is now a qualifying termination for CEO severance, and the pro-rata current-year bonus eligibility date in a qualifying termination moved from June 30 to March 31.
CFO Paul McGarry and CAO Christine Chang each have an employment agreement dated September 28, 2026, with a one-year initial term and unchanged prior compensation terms.
RSU and PSU vesting date moved from April 15 to March 17, and change-in-control protection period increased from 12 months to 24 months.
Exhibit 10.1 is indexed as an agreement with Xi Lin, while the filing text names Felix Lin as the CEO.
Veea Inc. received unsecured demand loans from NLabs Inc., a principal stockholder and affiliate of its CEO, on September 29, 2026, totaling $1.65 million. The notes carry a 10% annual interest rate and are payable by December 31, 2026 or on demand by NLabs, which adds short-term debt tied to a related party.
Four demand promissory notes from NLabs Inc.: $500,000, $500,000, $500,000 and $150,000, dated September 29, 2026
Interest accrues at 10% per year; principal and interest payable on the earlier of December 31, 2026 or demand by NLabs
Company may prepay without penalty; proceeds are for working capital
On October 1, 2026, Executive Vice President and General Counsel Christian T. Chandler notified Elmet Group of his decision to retire effective December 31, 2026. He will remain as an advisor on legal, regulatory and compliance matters. The company also posted an updated corporate presentation on its website, furnished as Exhibit 99.1, which describes a $450 million Department of War investment and the planned Schwabmünchen acquisition.
Chandler has served as General Counsel since the company's founding; retirement is effective December 31, 2026.
Chandler will continue to advise the company on legal, regulatory and compliance matters after retiring.
The presentation, published October 1, 2026, cites $450 million in committed Department of War investment, with $200 million at closing.
The presentation says the Schwabmünchen acquisition is expected to close in Q1 2027.
UGI Corporation's subsidiary Mountaineer Gas Company entered into a Note Purchase Agreement dated September 28, 2026, and funded $50 million of privately placed senior notes that day. Proceeds will be used primarily to refinance indebtedness and for general corporate purposes, and the filing describes the covenants and default terms that apply to the notes.
Series H notes: $30 million at 5.95%, maturing September 28, 2038
Series I notes: $20 million at 6.05%, maturing September 28, 2041
Notes are unsecured, with semiannual interest payments due March 28 and September 28
Covenants include a debt-to-capitalization ratio not above 0.65 to 1.00 and consolidated tangible net worth of at least $70 million
Meridian Holdings agreed on September 28, 2026 to defer the final $625,672 of an acquisition payment owed to the former MeridianBet owners to November 1, 2031, and to extend $15 million of promissory notes to the same date without interest unless a default occurs. On October 2, 2026, the board named Zhe 'Scott' Yan as principal financial and principal accounting officer, while William Scott remains President, CFO, Treasurer and Chairman.
Tenth Amendment (effective September 28, 2026): $10 million of the 12-month payment and $9,374,328 of the 18-month payment are confirmed as paid; $625,672 remains due by November 1, 2031, with no interest.
Second Notes Amendment: the $15 million promissory notes are extended to November 1, 2031, stop accruing interest unless an event of default occurs, and no longer require monthly interest payments.
October 2, 2026: Zhe 'Scott' Yan, the company's financial accounting manager, becomes Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer; William Scott stops serving as PFO and PAO.
Yan's expected salary is 280,000 Australian dollars per year; the filing also says Milosevic's base salary was cut from $396,000 to $216,000 effective January 1, 2026.
On September 28, 2026, NANO Nuclear and its subsidiary HALEU Energy Fuel agreed to buy U.S. nuclear fuel processing assets from Radnostix, Inc. (formerly International Isotopes) and its subsidiary. The assets include an NRC license tied to a previously planned depleted uranium hexafluoride deconversion plant in Lea County, New Mexico. Closing is subject to NRC approval of the license transfer and other conditions, so shareholders should note the deal is not yet completed.
Agreement dated September 28, 2026, with Radnostix, Inc. and International Isotopes Fluorine Products, Inc.
At closing, the buyers will pay $9.5 million in cash, less escrowed funds and lien payoffs, and issue $4 million of restricted common stock to Radnostix.
The parties expect closing in about 90 to 120 days, depending on NRC consent and other approvals.
The agreement can be terminated if the Hobbs Site condition is not met within 120 days after September 28, 2026, extendable by 60 days.
Cingulate Inc. amended the employment agreement of Matthew N. Brams, its Executive Vice President and Chief Medical Officer, on September 30, 2026. The amendment extends the trial period for his full-time employment from September 30, 2026 to December 31, 2026. This is an administrative change to an executive's employment terms and does not disclose any financial results or new compensation figures.
Amendment No. 2 to the employment agreement between Cingulate Therapeutics LLC and Matthew N. Brams was entered into on September 30, 2026, effective January 1, 2026 for the underlying agreement.
The trial period for Mr. Brams' full-time employment was extended from September 30, 2026 to December 31, 2026.
The full amendment is filed as Exhibit 10.1 to the 8-K.
On September 28, 2026, Starfighters Space's board and compensation committee raised CEO Tim Franta's base salary from $108,000 to $350,000 and CFO David Whitney's from $180,000 to $300,000, and approved back pay tied to those increases. The filing does not state the back-pay amounts, so shareholders cannot yet see the total cost of the change.
CEO Tim Franta: base salary raised from $108,000 to $350,000, with a maximum annual bonus of up to 50% of the new salary.
CFO David Whitney: base salary raised from $180,000 to $300,000, with a maximum annual bonus of up to 30% of the new salary.
Back pay covers Franta from March 1, 2026 and Whitney from June 24, 2026, through the September 28, 2026 effective date.
Bonus amounts above $75,000 are paid 65% in cash and 35% in restricted share units vesting over three years.
Aimco's Executive Vice President and Chief Administrative Officer, Jennifer Johnson, notified the company on October 1, 2026 that she will resign effective November 1, 2026 for Good Reason, which the company accepted, citing reduced duties tied to the shareholder-approved Plan of Sale and Liquidation. She will receive severance-related payments and benefits, and will then act as a consultant until May 2, 2027, which is a change in senior leadership during the company's liquidation process.
Resignation effective November 1, 2026, citing Good Reason tied to the Plan of Sale and Liquidation approved by shareholders on February 6, 2026
Post-resignation consulting arrangement runs until May 2, 2027, up to 10 hours per month at $750 per hour, plus expenses
Either party may end the consulting arrangement on 30 days' written notice
Separation Agreement dated October 1, 2026 is filed as Exhibit 10.1
BeyondSpring Inc. received a Nasdaq notice on September 29, 2026, stating its market value of listed securities has been below $35 million for 30 consecutive business days, so it no longer meets the continued listing requirement. The notice does not cause immediate delisting, and shares continue to trade on Nasdaq, but the company must regain compliance by March 29, 2027, or face a delisting process, which the company says it cannot assure.
Nasdaq notice received September 29, 2026 under Listing Rule 5550(b)(2)
Market value of listed securities fell below $35 million for 30 consecutive business days
Compliance period runs 180 calendar days, until March 29, 2027
Shares continue to trade on Nasdaq during the compliance period
Fog Cutter Holdings LLC bought the sponsor's shares and private units in Tavia Acquisition Corp. (TAVI) and took over sponsor duties, closing October 1, 2026. Andrew Wiederhorn, Chairman and CEO of Fog Cutter, became Executive Chairman and CEO, and Kenneth Kuick became CFO, as the board was reshaped.
Closing occurred October 1, 2026; Fog Cutter bought 2,243,333 ordinary shares and 249,107 private units from the sponsor
Sponsor retained 1,500,000 ordinary shares; Fog Cutter funds monthly trust contributions of up to $60,000 and operating expenses from October 1, 2026
Andrew Wiederhorn appointed Executive Chairman and CEO and Kenneth Kuick CFO, both effective October 1, 2026; three directors resigned September 28, 2026 and Askar Mametov resigned October 1, 2026
Newell Brands and its special purpose subsidiary Jarden Receivables renewed their receivables purchase agreement with Royal Bank of Canada as administrative agent and signed a second amendment. The facility limit on factored receivables is set at $75 million, and the maturity is extended to October 1, 2027. The filing also raises the debt rating thresholds that set the facility's rating-based levels, which affects the terms under which the facility operates.
Scheduled Termination Date extended to October 1, 2027
Facility Limit on factored receivables adjusted to $75 million
Concentration Limits increased for all Obligor groups
Debt Rating now based on corporate rating from S&P or Moody's, with higher thresholds for Levels 1, 2 and 3
Bank of Marin Bancorp said it will release third quarter 2026 financial results and hold an earnings webcast on Monday, October 26, 2026, at 8:30 a.m. PT. The filing contains only the scheduling announcement and attaches an October 2, 2026 press release, so no results are reported in this 8-K.
Results for the quarter ended September 30, 2026 will be released before the call on October 26, 2026.
Webcast set for 8:30 a.m. PT / 11:30 a.m. ET, with a replay available on the company's website afterward.
CEO Tim Myers and CFO Dave Bonaccorso will discuss the results on the call.
Broadway Financial agreed on September 28, 2026 to the resignation of John Allen, its Executive Vice President and Chief Banking Officer, effective December 31, 2026. Allen will serve in a transition capacity through that date, and the company will review the role's structure and decide whether to search for a successor.
Resignation agreed September 28, 2026; effective December 31, 2026
John Allen, Executive Vice President and Chief Banking Officer, to serve in a transition capacity through December 31, 2026
Company will evaluate the position's structure, scope and responsibilities before deciding on next steps, including a possible successor search
Quantum Computing Inc. posted an updated investor presentation to its website on October 2, 2026, and furnished it as Exhibit 99.1 under Regulation FD. The deck restates first-half 2026 results, including $9.2 million in revenue and a $15.8 million net loss, and lists a $1.3 billion cash and investments balance with no debt.
First-half 2026 revenue was $9.2 million, with operating expenses of $41.7 million and a net loss of $15.8 million.
Cash and investments were $1.3 billion with no debt, as of the presentation date.
Reported backlog was $42.5 million as of June 30, 2026.
Three acquisitions completed in 2026 had a total cost of $195 million in cash plus $7.5 million in QUBT shares, with up to $72 million in possible earn-outs.
WesBanco announced it will release its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026, and host a conference call on Thursday, October 22, 2026 at 3:00 p.m. ET. The filing is a scheduling notice only and does not contain the quarter's financial results.
Third quarter 2026 results expected after market close on Wednesday, October 21, 2026
Conference call with CEO Jeff Jackson and CFO Dan Weiss at 3:00 p.m. ET on Thursday, October 22, 2026
Replay available from approximately 5:00 p.m. ET on October 22, 2026 through November 5, 2026
Amentum Holdings' board approved an amended and restated employment agreement for Executive Chair Steven J. Demetriou, effective September 28, 2026. The filing sets a $625,000 base salary, a bonus at 100% of base salary, and a $1,250,000 long-term incentive target, and removes severance obligations except a pro-rata bonus and full accelerated vesting of outstanding LTI awards.
Base salary set at $625,000, effective September 28, 2026
Short-term bonus target is 100% of base salary
Long-term incentive target value at grant is $1,250,000
Severance removed, except pro-rata bonus and full accelerated LTI vesting
International Money Express refiled its antitrust notification under the HSR Act on October 2, 2026, because the original clearance expires one year after its waiting period ended. A new 30-day waiting period starts, and the California DFPI, which suspended its merger approval, is not expected to reinstate it before October 6, 2026. The Western Union merger remains pending and may take longer to close, which keeps shareholders waiting on the deal.
The original HSR waiting period expired at 11:59 p.m. Eastern Time on October 6, 2025, and clearance is effective for one year.
On October 2, 2026, the company and Western Union each filed HSR notification forms, starting a new 30-day waiting period; early termination was requested.
The DFPI suspended its approval of the merger, and the parties do not expect reinstatement before October 6, 2026.
Closing still requires the new HSR waiting period to expire or terminate, DFPI approval to be reinstated, and other closing conditions to be met.
Prothena disclosed that Chief Development Officer Chad J. Swanson, Ph.D., notified the company on October 2, 2026, that he is resigning effective October 9, 2026. He is leaving to join one of Prothena's strategic partners, where he will lead a program partnered with the company.
Chad J. Swanson, Ph.D., Chief Development Officer, resigns effective October 9, 2026.
Notice of resignation was given to the company on October 2, 2026.
Swanson is joining a strategic partner and will lead a program partnered with Prothena.
The filing does not state a successor or interim arrangement.
Effective October 1, 2026, Jasper B. Sanfilippo, Jr. became chief executive officer, Jeffrey T. Sanfilippo moved to executive chair, and Frank Pellegrino was named president and chief financial officer. The filing also sets out Pellegrino's new pay package, which includes a higher base salary and additional equity awards, so the leadership change and its cost are relevant to shareholders.
Jasper B. Sanfilippo, Jr., previously chief operating officer, president and secretary, became CEO on October 1, 2026.
Jeffrey T. Sanfilippo, former CEO, became executive chair of the Board on October 1, 2026.
Pellegrino's base salary rose to $700,000 per year, with a target bonus of 100% of salary.
Pellegrino will receive a $600,000 annual equity award for fiscal 2027 plus a one-time $750,000 equity award.
Adial Pharmaceuticals, Inc. further adjourned the reconvened portion of its 2026 Annual Meeting because it had not yet received Nasdaq's approval of an Initial Listing Application tied to those proposals. Votes on Proposals 3, 4, 5 and 6 remain open, and the meeting will reconvene on October 15, 2026. The filing names Adial Pharmaceuticals, Inc. while the ticker given was AZR, so the company identity should be confirmed.
Proposals 1, 2, 7, 8, 9, 10, 11 and 12 were voted on earlier; votes on Proposals 3, 4, 5 and 6 are still pending.
The October 1, 2026 reconvened meeting was adjourned again while Nasdaq approval was still outstanding.
The adjourned meeting will reconvene October 15, 2026 at 8:30 a.m. Eastern Time in Charlottesville, Virginia.
The record date remains August 17, 2026; stockholders who already submitted proxies need not act unless they want to change their votes.
On October 1, 2026, ESCO Technologies completed its purchase of all shares of Megger Group Limited from TBG AG for about $2.3 billion, paid in $922 million cash and 5.10 million shares of common stock. The company funded the cash portion and refinancing with about $1.0 billion borrowed under a new credit agreement, which replaced its existing credit agreement. Shareholders face higher debt and dilution from the new shares, and the seller gains a board seat right while it holds at least 50% of the consideration shares.
Purchase price of about $2.3 billion: $922 million in cash and 5.10 million shares of common stock, subject to a cash post-closing adjustment for net debt and working capital
New $1.5 billion credit facilities (revolver, Term Loan A and Term Loan B, $500 million each) became effective on the closing date, with about $1.0 billion borrowed
Existing credit agreement, scheduled to mature August 30, 2028, was terminated on the closing date
Board increased from eight to nine members; Jeremy P. Abson elected as a director effective October 1, 2026
Greenland Mines Ltd. reported that director Jon McGarity resigned from its Board on September 28, 2026, saying the resignation was not due to any disagreement with the company. The Board appointed Peter Love and Blair Jordan to fill the vacancies effective immediately, and neither has been named to a Board committee yet. The change is a board composition update with no stated financial effect.
Jon McGarity resigned from the Board on September 28, 2026; the filing states no disagreement with the company.
Peter Love (age 47) and Blair Jordan (age 57) were appointed to the Board on September 28, 2026, to fill vacancies.
Both new directors will serve until the next annual meeting of stockholders; neither has been assigned to a committee.
Jordan previously led a restructuring and a US$425 million private placement at Forum Markets, Incorporated.
Voya Financial said executive Santhosh Keshavan, its Chief Technology and Operations Officer and a named executive officer, will take the role of Chief Risk and Global Operating Officer effective January 1, 2027. Rajat Kalia will become Chief Technology Officer at that time, so the filing describes a reassignment of senior roles rather than a change in the company's financial results.
Santhosh Keshavan moves to Chief Risk and Global Operating Officer, effective January 1, 2027
Rajat Kalia becomes Chief Technology Officer on the same date
The filing states the new role is not a principal operating officer position under Item 5.02
Announced October 2, 2026; filed by Julie Watson, Vice President, Counsel and Corporate Secretary
Velo3D said Chief Financial Officer James Suva separated from the company on September 28, 2026, and that the separation was not due to any disagreement on operations, policies or practices. The board named Terence P. Wynn interim CFO and principal financial and accounting officer, serving through a services agreement with KongBasileConsulting LLC at $32,500 per month.
James Suva separated as CFO effective September 28, 2026; the filing states no disagreement with the company on operations, policies or practices.
Terence P. Wynn appointed Interim CFO effective September 28, 2026, as a consultant paid via KongBasileConsulting LLC, not as a company employee.
The Company will pay KBC a monthly fee of $32,500 for Mr. Wynn's services, prorated for partial months, plus pre-approved expenses.
KBC may terminate on at least 60 days' written notice; the Company may terminate at any time on written notice.
Grove Collaborative's Board appointed Flip van den Bosch, the company's Controller, as principal financial officer and principal accounting officer, effective October 1, 2026. The Compensation Committee approved a $25,000 retention bonus, a base salary increase to $261,397, and restricted stock units covering 30,000 Class A shares, which matter to shareholders as they set the pay terms for the company's senior finance role.
Flip van den Bosch, age 38, takes the principal financial officer and principal accounting officer roles effective October 1, 2026.
He has been Controller since March 2025 and has worked in the finance department since October 2022; previously he was at PricewaterhouseCoopers from September 2012 to October 2022.
Pay terms: $25,000 one-time cash retention bonus through May 15, 2027; base salary raised to $261,397 effective September 1, 2026; RSUs covering 30,000 shares vesting 15,000 on May 15, 2027 and 15,000 on August 15, 2027.
Nano Dimension dismissed KPMG LLP as its independent auditor on September 28, 2026, and engaged Kesselman & Kesselman (PwC Israel) as successor, starting with the 2026 year-end audit and the Q3 2026 review. KPMG's report on internal control over financial reporting for fiscal 2025 contained an adverse opinion tied to a material weakness in accounting for acquisitions and discontinued operations, which shareholders should weigh alongside the change.
KPMG dismissed September 28, 2026; the Audit Committee approved the change.
KPMG's internal control report, dated March 31, 2026, was adverse, citing insufficient accounting resources affecting controls over acquisitions, including valuation of certain acquired intangible assets and discontinued operations.
PwC Israel engaged September 28, 2026, for the year ending December 31, 2026 audit and the quarter ending September 30, 2026 review.
KPMG's letter dated October 2, 2026, is filed as Exhibit 16.1.
BioAge Labs said the first participant has been dosed in QUELL-DME, a randomized, controlled Phase 2 trial of once-daily oral BGE-102 in adults with diabetic macular edema. The filing also updated the trial design, with topline results expected in the second half of 2027, which is a clinical milestone rather than a financial result for shareholders.
First participant dosed in QUELL-DME, a Phase 2 trial of oral BGE-102, an NLRP3 inhibitor
Trial plans about 180 participants randomized 1:1:1 across three arms over 12 weeks of dosing, with a four-week follow-up
Primary endpoint is change in best-corrected visual acuity at week 12
Topline results expected in the second half of 2027
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.